PART I Corporate Information We were originally incorporated in the State of Delaware in April 2003 as PharmacoFore, Inc. and, in January 2012, we changed our name from PharmacoFore, Inc. to Signature Therapeutics Inc. ( Signature ). In December 2015, Signature merged with and into Ensysce Biosciences, Inc. ( Former Ensysce ). In June 2021, Former Ensysce merged with and into Leisure Acquisition Corporation ( LACQ ). As part of the transaction, LACQ changed its name to Ensysce Biosciences, Inc. ...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013633 | EDGAR | 84K words |
| 2025-03-10 | 2024-12-31 | 0001493152-25-009703 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001493152-24-009993 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001493152-23-009844 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008438 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001213900-21-015361 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001213900-20-005867 | EDGAR | — |
| 2019-03-11 | 2018-12-31 | 0001615774-19-003912 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001615774-18-001769 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-023498 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023512 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001641172-25-009955 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044768 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032263 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018718 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040091 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001493152-23-027659 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017430 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032094 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001493152-22-022103 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-013083 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-03 | 0001493152-26-015139 | EDGAR | 1K words |
| 2026-03-30 | 0001493152-26-013622 | EDGAR | — |
| 2026-03-30 | 0001493152-26-013314 | EDGAR | — |
| 2026-03-23 | 0001493152-26-012062 | EDGAR | — |
| 2026-02-27 | 0001493152-26-008343 | EDGAR | — |
| 2026-01-08 | 0001493152-26-000994 | EDGAR | — |
| 2025-11-17 | 0001493152-25-023933 | EDGAR | — |
| 2025-11-14 | 0001493152-25-023492 | EDGAR | — |
| 2025-08-13 | 0001641172-25-023500 | EDGAR | — |
| 2025-06-05 | 0001641172-25-013853 | EDGAR | — |
203 total filings indexed. 172 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001716947 |
| Ticker | ENSC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ensysce.com |
| Listed | 2021-07-01 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report